Tag Archives: BIIB

No Comments

Blogging Options: CBOE Morning Update 4.15.15

BAC off fractionally as earnings swing to positive ($5.6B less in legal fees helps) but revenue misses.  DAL up $0.50 but even as earnings met, DAL sees turbulance with dollar ahead. GOOG with EU problems this morning. Several Chinese economic numbers missed overnight.  Oil up ~1%.  Empire State Manufacturing off ~1.2% for April (+6.9% March, […]






No Comments

Blogging Options: CBOE Morning Update 3.20.15

Happy Triple Witch Friday.   Spring officially arrives right after the close today.  European debt talks have some optimistic, DAX up 1%.  Commodities flat, DRI up $2.50 on good Quarter.  For those following the NCAA tournament, Matt Moran from CBOE will post his “Volatility Bracketology” here at the CBOE Hub later this morning, it’s a good […]






No Comments

CBOE Mid-Day Update 1.30.15

Volatility as an asset class Biogen (BIIB) is recently up $34.93 to $388.54 on Q4 profit nearly doubling. February weekly call option implied volatility is at 37, February is at 34, March is at 32, April is at 35; compared to its 26-week average of 32. MasterCard (MA) is recently up 54c to $81.86 on […]






No Comments

CBOE Mid-Day Update 7.23.14

Volatility as an asset class Boeing (BA) is recently down $3.21 to $126.53 after raising 2014 EPS outlook, however renewed concerns on the KC-46 tanker program and a $425M charge on Pegasus jets. July weekly call option implied volatility is at 23, August is at 18, October is at 15; compared to its 26-week average […]